Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data.
Duarte
R F
RF
Department of Haematology, Catalan Institute of Oncology, Barcelona, Spain. rduarte@iconcologia.net
Shaw
B E
BE
Marín
P
P
Kottaridis
P
P
Ortiz
M
M
Morante
C
C
Delgado
J
J
Gayoso
J
J
Goterriz
R
R
Martínez-Chamorro
C
C
Mateos-Mazón
J J
JJ
Ramírez
C
C
de la Rubia
J
J
Achtereekte
H
H
Gandhi
P J
PJ
Douglas
K W
KW
Russell
N H
NH
D000328:Adult; D000368:Aged; D018952:Antigens, CD34 / Q000097:blood; D001596:Benzylamines; D015331:Cohort Studies; D057176:Compassionate Use Trials; D000080027:Cyclams; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005062:European Union; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D019650:Hematopoietic Stem Cell Mobilization / Q000009:adverse effects / Q000379:methods*; D006571:Heterocyclic Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D018952:Antigens, CD34; D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D016179:Granulocyte Colony-Stimulating Factor; C088327:plerixafor